Brut and NAST are not a ladder
The natural assumption is that Brut is the beginner version and NAST is what you graduate to. That is not the relationship. They answer different questions about what is scarce.
| Brut | NAST | |
|---|---|---|
| Assumes the constraint is | Adherence | Available levers |
| Time | ~1 hour/day | ~4 hours/day |
| Cost | ~£75–150/month | ~£285–520/month, more with imaging |
| Levers | 9 | ~35 |
| Failure mode | Leaves ceiling unclaimed | Collapses entirely on a bad month |
| Right for | Almost everyone, almost always | A specific season with slack in it |
The maths that should decide it: a maximal protocol run at 60% adherence loses to a minimal one run at 95%, because nearly everything here is dose-over-time rather than dose-per-session. NAST only wins if you will genuinely run it at 90%+. Most people running NAST are running Brut badly and paying four times as much for the privilege.
A large fraction of what makes a protocol maximal is pharmacological, and essentially all of that is inappropriate before the mid-twenties — mTOR inhibition, GLP-1 agonists, growth-hormone-axis work, hormone modulation, aggressive caloric restriction. Under ~25 the maximal protocol and the free protocol are much closer together than the supplement industry would like, because the exotic tier is either useless or harmful in a body still finishing development. NAST at 17 means the behavioural and measurement columns run flawlessly, and nothing else.